330 related articles for article (PubMed ID: 29605688)
1. HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor.
Nowak J; Nestorowicz K; Graczyk-Pol E; Mika-Witkowska R; Rogatko-Koros M; Jaskula E; Koscinska K; Madej S; Tomaszewska A; Nasilowska-Adamska B; Szczepinski A; Halaburda K; Dybko J; Kuliczkowski K; Czerw T; Giebel S; Holowiecki J; Baranska M; Pieczonka A; Wachowiak J; Czyz A; Gil L; Lojko-Dankowska A; Komarnicki M; Bieniaszewska M; Kucharska A; Hellmann A; Gronkowska A; Jedrzejczak WW; Markiewicz M; Koclega A; Kyrcz-Krzemien S; Mielcarek M; Kalwak K; Styczynski J; Wysocki M; Drabko K; Wojcik B; Kowalczyk J; Gozdzik J; Pawliczak D; Gwozdowicz S; Dziopa J; Szlendak U; Witkowska A; Zubala M; Gawron A; Warzocha K; Lange A
Hum Immunol; 2018 Jun; 79(6):403-412. PubMed ID: 29605688
[TBL] [Abstract][Full Text] [Related]
2. Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.
Petersdorf EW; Malkki M; Horowitz MM; Spellman SR; Haagenson MD; Wang T
Blood; 2013 Mar; 121(10):1896-905. PubMed ID: 23305741
[TBL] [Abstract][Full Text] [Related]
3. Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation.
Rockstroh A; Al-Ali HK; Lange T; Pönisch W; Krahl R; Cross M; Behre G; Niederwieser D; Pfrepper C
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2193-203. PubMed ID: 26129640
[TBL] [Abstract][Full Text] [Related]
4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
5. HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.
Maeda Y; Ugai T; Kondo E; Ikegame K; Murata M; Uchida N; Miyamoto T; Takahashi S; Ohashi K; Nakamae H; Fukuda T; Onizuka M; Eto T; Ota S; Hirokawa M; Ichinohe T; Atsuta Y; Kanda Y; Kanda J;
Haematologica; 2019 May; 104(5):1055-1061. PubMed ID: 30523056
[TBL] [Abstract][Full Text] [Related]
6. MHC haplotype matching for unrelated hematopoietic cell transplantation.
Petersdorf EW; Malkki M; Gooley TA; Martin PJ; Guo Z
PLoS Med; 2007 Jan; 4(1):e8. PubMed ID: 17378697
[TBL] [Abstract][Full Text] [Related]
7. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.
Bettens F; Passweg J; Schanz U; Chalandon Y; Heim D; Güngör T; Stussi G; Nicoloso G; Baldomero H; Gratwohl A; Tiercy JM
Biol Blood Marrow Transplant; 2012 Apr; 18(4):608-16. PubMed ID: 21963878
[TBL] [Abstract][Full Text] [Related]
8. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
[TBL] [Abstract][Full Text] [Related]
9. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
[TBL] [Abstract][Full Text] [Related]
11. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
[TBL] [Abstract][Full Text] [Related]
12. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
[TBL] [Abstract][Full Text] [Related]
13. Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation.
Kanda Y; Kanda J; Atsuta Y; Fuji S; Maeda Y; Ichinohe T; Takanashi M; Ohashi K; Fukuda T; Miyamura K; Mori T; Sao H; Kobayashi N; Iwato K; Sawada A; Mori S;
Biol Blood Marrow Transplant; 2014 Apr; 20(4):526-35. PubMed ID: 24417871
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors.
Petersdorf EW; Gooley T; Malkki M; Horowitz M;
Tissue Antigens; 2007 Apr; 69 Suppl 1():25-30. PubMed ID: 17445158
[TBL] [Abstract][Full Text] [Related]
15. A single-center analysis of chronic graft-versus-host disease-free, relapse-free survival after alternative donor stem cell transplantation in children with hematological malignancies.
Inagaki J; Fukano R; Noguchi M; Okamura J
Int J Hematol; 2017 May; 105(5):676-685. PubMed ID: 28205066
[TBL] [Abstract][Full Text] [Related]
16. Role of donor HLA class I mismatch, KIR-ligand mismatch and HLA:KIR pairings in hematological malignancy relapse after unrelated hematopoietic stem cell transplantation.
Graczyk-Pol E; Rogatko-Koros M; Nestorowicz K; Gwozdowicz S; Mika-Witkowska R; Pawliczak D; Zubala M; Szlendak U; Witkowska A; Tomaszewska A; Nasilowska-Adamska B; Szczepinski A; Wojcik M; Halaburda K; Nowak J
HLA; 2018 Dec; 92 Suppl 2():42-46. PubMed ID: 30168290
[TBL] [Abstract][Full Text] [Related]
17. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
18. The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.
Sakellari I; Batsis I; Bousiou Z; Mallouri D; Constantinou V; Gavriilaki E; Smias C; Yannaki E; Kaloyannidis P; Papaioannou G; Stavroyianni N; Syrigou A; Sotiropoulos D; Fylaktou A; Tsompanakou A; Saloum R; Anagnostopoulos A
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):658-666. PubMed ID: 28716402
[TBL] [Abstract][Full Text] [Related]
19. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
20. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
